Monday, December 23, 2024
HomeTagsLowers the Risk

Lowers the Risk

New Data Show FARXIGA Significantly Lowers the Risk of Cardiovascular Death in Patients

New results from a pre-specified, patient level, pooled analysis from the Phase III DAPA-HF and DELIVER trials demonstrated mortality benefit of FARXIGA® (dapagliflozin), compared...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics